These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8833449)

  • 1. Synaptic regulation of mesocorticolimbic dopamine neurons.
    White FJ
    Annu Rev Neurosci; 1996; 19():405-36. PubMed ID: 8833449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights to drug addiction derived from ultrastructural views of the mesocorticolimbic system.
    Morales M; Pickel VM
    Ann N Y Acad Sci; 2012 Feb; 1248():71-88. PubMed ID: 22171551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic plasticity in the mesolimbic dopamine system.
    Thomas MJ; Malenka RC
    Philos Trans R Soc Lond B Biol Sci; 2003 Apr; 358(1432):815-9. PubMed ID: 12740128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems.
    Adell A; Artigas F
    Neurosci Biobehav Rev; 2004 Jul; 28(4):415-31. PubMed ID: 15289006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area.
    Sesack SR; Pickel VM
    J Comp Neurol; 1992 Jun; 320(2):145-60. PubMed ID: 1377716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic inhibition of gamma-aminobutyric acidB-mediated synaptic current by adenosine recorded in vitro in midbrain dopamine neurons.
    Wu YN; Mercuri NB; Johnson SW
    J Pharmacol Exp Ther; 1995 May; 273(2):576-81. PubMed ID: 7752058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of presumed dopamine neurons in the ventral tegmental area during heroin self-administration.
    Kiyatkin EA; Rebec GV
    Neuroreport; 1997 Jul; 8(11):2581-5. PubMed ID: 9261831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the dopaminergic mesocorticolimbic system necessary for intracranial self-stimulation? Biochemical and behavioral studies from A10 cell bodies and terminals.
    Simon H; Stinus L; Tassin JP; Lavielle S; Blanc G; Thierry AM; Glowinski J; Le Moal M
    Behav Neural Biol; 1979 Oct; 27(2):125-45. PubMed ID: 508212
    [No Abstract]   [Full Text] [Related]  

  • 9. Electrophysiological evidence for the presence of ionotropic and metabotropic excitatory amino acid receptors on dopaminergic neurons of the rat mesencephalon: an in vitro study.
    Mercuri NB; Stratta F; Calabresi P; Bernardi G
    Funct Neurol; 1992; 7(3):231-4. PubMed ID: 1323507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.
    Skarsfeldt T
    Synapse; 1992 Jan; 10(1):25-33. PubMed ID: 1346943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal.
    Pu L; Liu QS; Poo MM
    Nat Neurosci; 2006 May; 9(5):605-7. PubMed ID: 16633344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction?
    Bonci A; Bernardi G; Grillner P; Mercuri NB
    Trends Pharmacol Sci; 2003 Apr; 24(4):172-7. PubMed ID: 12707003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific limbic circuit underlies opiate withdrawal memories.
    Frenois F; Stinus L; Di Blasi F; Cador M; Le Moine C
    J Neurosci; 2005 Feb; 25(6):1366-74. PubMed ID: 15703390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burst firing of mesencephalic dopamine neurons is inhibited by somatodendritic application of kynurenate.
    Charlety PJ; Grenhoff J; Chergui K; De la Chapelle B; Buda M; Svensson TH; Chouvet G
    Acta Physiol Scand; 1991 May; 142(1):105-12. PubMed ID: 1877358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfonylureas enhance GABAA synaptic potentials in rat midbrain dopamine neurones.
    Grenhoff J; Johnson SW
    Acta Physiol Scand; 1996 Feb; 156(2):147-8. PubMed ID: 8868271
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine and serotonin release-regulating autoreceptor sensitivity in A9/A10 cell body and terminal areas after withdrawal of rats from continuous infusion of cocaine.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1445-53. PubMed ID: 8263807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norepinephrine-dopamine interactions in the prefrontal cortex and the ventral tegmental area: relevance to mental diseases.
    Tassin JP
    Adv Pharmacol; 1998; 42():712-6. PubMed ID: 9327998
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Firing patterns of midbrain dopamine neurons: differences between A9 and A10 cells.
    Grenhoff J; Ugedo L; Svensson TH
    Acta Physiol Scand; 1988 Sep; 134(1):127-32. PubMed ID: 3239415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple mechanisms of withdrawal from opioid drugs.
    Redmond DE; Krystal JH
    Annu Rev Neurosci; 1984; 7():443-78. PubMed ID: 6324646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.